FDA spurs development of COVID-19 tests for use outside labs

By LabPulse.com staff writers

July 30, 2020 -- The U.S. Food and Drug Administration (FDA) has published a template to help commercial companies develop COVID-19 molecular diagnostic and antigen tests that can be used completely outside of laboratory environments and without a prescription.

The template was designed to support filings of emergency use authorizations for nonlaboratory tests during the COVID-19 pandemic. Such tests could be deployed in workplaces or schools. The aim is to spur development of tests that may be used at home, much like a pregnancy kit. Sensitivity of home tests is lower than those done in labs, but much broader access outweighs this downside, the agency said in a statement.

"We hope that with the innovation we've seen in test development, we could see tests that you could buy at a drug store, swab your nose or collect saliva, run the test, and receive results within minutes at home, once these tests become available," FDA Commissioner Dr. Stephen Hahn said.

Other recent initiatives aimed at expanding the range of testing options as states reopen economies include emergency authorizations for asymptomatic testing and pooled testing of samples for up to five individual swab specimens.

FDA clears LabCorp's COVID-19 test for asymptomatic use
The U.S. Food and Drug Administration (FDA) has cleared LabCorp's COVID-19 reverse transcription polymerase chain reaction test for use in screening asymptomatic...
Coronavirus testing in schools is a work in progress
Officials on the White House Coronavirus Task Force are urging the reopening of schools and suggested that antigen testing and saliva specimen collection...
Study finds COVID-19 self-collected swabs on par with physician samples
Specimens that were self-collected by COVID-19 outpatients produced diagnostic outcomes that were nearly identical to those from physician-collected samples...
BioIQ, P23 launch home saliva panel test for COVID-19, flu
BioIQ and P23 labs have partnered to create an at-home COVID-19 test that screens a single self-collected saliva sample for SARS-CoV-2, influenza A, influenza...
FDA creates template for emergency clearance of at-home COVID-19 tests
The U.S. Food and Drug Administration (FDA) has created a template to clarify and smooth the way toward obtaining emergency use authorization for at-home...

Copyright © 2020 LabPulse.com

Last Updated ls 7/30/2020 1:51:41 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email